They got $15m in cash at hand according to their latest statement.
3.5 is at 31/12/23, should have been mentioned by JC.
Ann 18/01/24
ASX ANNOUNCEMENT 18 JANUARY 2024 Placement of Entitlement Offer Shortfall • Placement of Entitlement Offer Shortfall of approx. $3.20m from institutional and sophisticated investors • Takes the total amount subscribed under the entitlement offer and entitlement offer shortfall placement to $7.66m (before costs) • Current approximate cash position of $15m which will fund the advancement of the Company’s clinical trials programs in Glioblastoma, Gastrointestinal Tumours and Acute Myeloid Leukemi
CHM Price at posting:
2.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)